Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome.
暂无分享,去创建一个
L. Eapen | G. Perry | S. Dahrouge | J. Crook | S. Malone | V. Gallant | R. Segal | J. Spaans
暂无分享,去创建一个
L. Eapen | G. Perry | S. Dahrouge | J. Crook | S. Malone | V. Gallant | R. Segal | J. Spaans